Structural basis of nanobodies targeting the prototype norovirus

Human norovirus infections are a major disease burden. In this study, we analyzed three new norovirus-specific Nanobodies that interacted with the prototype human norovirus (i.e., genogroup I genotype 1 [GI.1]). We showed that the Nanobodies bound on the side (Nano-7 and Nano-62) and top (Nano-94) o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Ruoff, Kerstin (VerfasserIn) , Kiliç, Turgay (VerfasserIn) , Devant, Jessica (VerfasserIn) , Hansman, Grant S. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 5, 2019
In: Journal of virology
Year: 2019, Jahrgang: 93, Heft: 6
ISSN:1098-5514
DOI:10.1128/JVI.02005-18
Online-Zugang:Verlag, Volltext: https://doi.org/10.1128/JVI.02005-18
Verlag, Volltext: https://jvi.asm.org/content/93/6/e02005-18
Volltext
Verfasserangaben:Kerstin Ruoff, Turgay Kilic, Jessica Devant, Anna Koromyslova, Alessa Ringel, Alexander Hempelmann, Celina Geiss, Juliane Graf, Michelle Haas, Imme Roggenbach, Grant Hansman

MARC

LEADER 00000caa a2200000 c 4500
001 1668104652
003 DE-627
005 20230426163610.0
007 cr uuu---uuuuu
008 190628s2019 xx |||||o 00| ||eng c
024 7 |a 10.1128/JVI.02005-18  |2 doi 
035 |a (DE-627)1668104652 
035 |a (DE-599)KXP1668104652 
035 |a (OCoLC)1341230336 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Ruoff, Kerstin  |d 1991-  |e VerfasserIn  |0 (DE-588)1189452251  |0 (DE-627)1668103435  |4 aut 
245 1 0 |a Structural basis of nanobodies targeting the prototype norovirus  |c Kerstin Ruoff, Turgay Kilic, Jessica Devant, Anna Koromyslova, Alessa Ringel, Alexander Hempelmann, Celina Geiss, Juliane Graf, Michelle Haas, Imme Roggenbach, Grant Hansman 
264 1 |c March 5, 2019 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.06.2019 
520 |a Human norovirus infections are a major disease burden. In this study, we analyzed three new norovirus-specific Nanobodies that interacted with the prototype human norovirus (i.e., genogroup I genotype 1 [GI.1]). We showed that the Nanobodies bound on the side (Nano-7 and Nano-62) and top (Nano-94) of the capsid-protruding (P) domain using X-ray crystallography. Nano-7 and Nano-62 bound at a similar region on the P domain, but the orientations of these two Nanobodies clashed with the shell (S) domain and neighboring P domains on intact particles. This finding suggested that the P domains on the particles should shift in order for Nano-7 and Nano-62 to bind to intact particles. Interestingly, both Nano-7 and Nano-94 were capable of blocking norovirus virus-like particles (VLPs) from binding to histo-blood group antigens (HBGAs), which are important cofactors for norovirus infection. Previously, we showed that the GI.1 HBGA pocket could be blocked with the soluble human milk oligosaccharide 2-fucosyllactose (2′FL). In the current study, we showed that a combined treatment of Nano-7 or Nano-94 with 2′FL enhanced the blocking potential with an additive (Nano-7) or synergistic (Nano-94) effect. We also found that GII Nanobodies with 2′FL also enhanced inhibition. The Nanobody inhibition likely occurred by different mechanisms, including particle aggregation or particle disassembly, whereas 2′FL blocked the HBGA binding site. Overall, these new data showed that the positive effect of the addition of 2′FL was not limited to a single mode of action of Nanobodies or to a single norovirus genogroup. - IMPORTANCE The discovery of vulnerable regions on norovirus particles is instrumental in the development of effective inhibitors, particularly for GI noroviruses that are genetically diverse. Analysis of these GI.1-specific Nanobodies has shown that similar to GII norovirus particles, the GI particles have vulnerable regions. The only known cofactor region, the HBGA binding pocket, represents the main target for inhibition. With a combination treatment, i.e., the addition of Nano-7 or Nano-94 with 2′FL, the effect of inhibition was increased. Therefore, combination drug treatments might offer a better approach to combat norovirus infections, especially since the GI genotypes are highly diverse and are continually changing the capsid landscape, and few conserved epitopes have so far been identified. 
700 1 |a Kiliç, Turgay  |e VerfasserIn  |0 (DE-588)133086151  |0 (DE-627)534478972  |0 (DE-576)26526121X  |4 aut 
700 1 |a Devant, Jessica  |d 1992-  |e VerfasserIn  |0 (DE-588)1189452464  |0 (DE-627)1668103915  |4 aut 
700 1 |a Hansman, Grant S.  |e VerfasserIn  |0 (DE-588)105917703X  |0 (DE-627)798127287  |0 (DE-576)325655553  |4 aut 
773 0 8 |i Enthalten in  |t Journal of virology  |d Baltimore, Md. : Soc., 1967  |g 93(2019,6) Artikel-Nummer e02005-18, 19 Seiten  |h Online-Ressource  |w (DE-627)303614609  |w (DE-600)1495529-5  |w (DE-576)08088766X  |x 1098-5514  |7 nnas  |a Structural basis of nanobodies targeting the prototype norovirus 
773 1 8 |g volume:93  |g year:2019  |g number:6  |g extent:19  |a Structural basis of nanobodies targeting the prototype norovirus 
856 4 0 |u https://doi.org/10.1128/JVI.02005-18  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://jvi.asm.org/content/93/6/e02005-18  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190628 
993 |a Article 
994 |a 2019 
998 |g 105917703X  |a Hansman, Grant S.  |m 105917703X:Hansman, Grant S.  |d 910000  |d 911700  |e 910000PH105917703X  |e 911700PH105917703X  |k 0/910000/  |k 1/910000/911700/  |p 11  |y j 
998 |g 1189452464  |a Devant, Jessica  |m 1189452464:Devant, Jessica  |d 910000  |d 911700  |e 910000PD1189452464  |e 911700PD1189452464  |k 0/910000/  |k 1/910000/911700/  |p 3 
998 |g 133086151  |a Kiliç, Turgay  |m 133086151:Kiliç, Turgay  |d 910000  |d 911700  |e 910000PK133086151  |e 911700PK133086151  |k 0/910000/  |k 1/910000/911700/  |p 2 
998 |g 1189452251  |a Ruoff, Kerstin  |m 1189452251:Ruoff, Kerstin  |d 910000  |d 911700  |e 910000PR1189452251  |e 911700PR1189452251  |k 0/910000/  |k 1/910000/911700/  |p 1  |x j 
999 |a KXP-PPN1668104652  |e 3490173295 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"March 5, 2019"}],"id":{"doi":["10.1128/JVI.02005-18"],"eki":["1668104652"]},"name":{"displayForm":["Kerstin Ruoff, Turgay Kilic, Jessica Devant, Anna Koromyslova, Alessa Ringel, Alexander Hempelmann, Celina Geiss, Juliane Graf, Michelle Haas, Imme Roggenbach, Grant Hansman"]},"physDesc":[{"extent":"19 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1967-","publisher":"Soc.","dateIssuedKey":"1967","publisherPlace":"Baltimore, Md."}],"id":{"zdb":["1495529-5"],"eki":["303614609"],"issn":["1098-5514"]},"disp":"Structural basis of nanobodies targeting the prototype norovirusJournal of virology","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 13.12.2021"],"recId":"303614609","corporate":[{"display":"American Society for Microbiology","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"],"pubHistory":["1.1967 -"],"part":{"text":"93(2019,6) Artikel-Nummer e02005-18, 19 Seiten","volume":"93","extent":"19","year":"2019","issue":"6"},"title":[{"title_sort":"Journal of virology","subtitle":"publ. by the American Society for Microbiology","title":"Journal of virology"}]}],"title":[{"title_sort":"Structural basis of nanobodies targeting the prototype norovirus","title":"Structural basis of nanobodies targeting the prototype norovirus"}],"person":[{"roleDisplay":"VerfasserIn","display":"Ruoff, Kerstin","role":"aut","family":"Ruoff","given":"Kerstin"},{"given":"Turgay","family":"Kiliç","role":"aut","roleDisplay":"VerfasserIn","display":"Kiliç, Turgay"},{"display":"Devant, Jessica","roleDisplay":"VerfasserIn","role":"aut","family":"Devant","given":"Jessica"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Hansman, Grant S.","given":"Grant S.","family":"Hansman"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 28.06.2019"],"language":["eng"],"recId":"1668104652"} 
SRT |a RUOFFKERSTSTRUCTURAL5201